|
|
Effect of Huoxue Huayu Yangxin Decoction combined with auricular point sticking and pressing on unstable angina pectoris after coronary stenting with qi deficiency and blood stasis syndrome |
DAI Yu YANG Jing LEI Dongxue LIU Huaying |
Department of Cardiovascular Medicine, Tangshan Traditional Chinese Medicine Hospital, Hebei Province, Tangshan 063000, China
|
|
|
Abstract Objective To investigate the effect of Huoxue Huayu Yangxin Decoction combined with auricular point sticking and pressing on unstable angina pectoris after coronary stenting with qi deficiency and blood stasis syndrome. Methods A total of 122 patients with unstable angina pectoris after coronary stenting treated in Tangshan Traditional Chinese Medicine Hospital of Hebei Province from May 2020 to May 2022 were selected as the study objects, and they were divided into the control group (61 cases with oral conventional western medicine) and the experimental group (61 cases with Huoxue Huayu Yangxin Decoction combined with auricular point sticking and pressing treatment on the basis of the control group) by random number table method. Seven days for one course of treatment, both groups were treated for four courses. The traditional Chinese medicine syndrome score, clinical efficacy, coronary hemodynamics, and treatment safety were compared between the two groups. Results After treatment, the traditional Chinese medicine syndrome scores of both groups were lower than before treatment, and those of the experimental group were lower than those of the control group, the differences were statistically significant (P<0.05). The clinical efficacy of the experimental group was better than that of the control group, and the difference was statistically significant (P<0.05). After treatment, the peak systolic velocity (PSV), end diastolic velocity (EDV), and pulsatility index (PI) of the two groups were higher than before treatment, and the PSV, EDV, and PI of the experimental group were higher than those of the control group, the differences were statistically significant (P<0.05). The resistance index (RI) of the two groups was lower than before treatment, and the RI of the experimental group was lower than that of the control group, the differences were statistically significant (P<0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P>0.05). Conclusion The effect of Huoxue Huayu Yangxin Decoction combined with auricular point sticking and pressing on unstable angina pectoris after coronary stenting is remarkable, which can improve the symptoms and coronary hemodynamics of patients with good safety.
|
|
|
|
|
[1] 盛耀,侯静波.冠脉支架内再狭窄治疗策略研究的进展[J].心血管康复医学杂志,2021,30(2):234-237.
[2] Carrera A,Contorni F,Gambacciani A,et al. Peripheral bare- metal stent implantation for a very-late stenosis of an aortic-left main Cabrol graft:a case report [J]. Eur Heart J Case Rep,2022,6(3):96-99.
[3] 毕明辉,柯志福,张广辉.宁心通痹汤联合阿利沙坦酯治疗冠心病不稳定型心绞痛患者的临床效果[J].中国当代医药,2022,29(19):143-146,154.
[4] 侯江红,吴秀娟,王一锦,等.心脉通胶囊联合曲美他嗪治疗不稳定型心绞痛的临床研究[J].现代药物与临床,2020,35(6):1156-1160.
[5] 李建平,李阳华,栗洋,等.尼可地尔联合单硝酸异山梨酯治疗不稳定型心绞痛的临床疗效及对炎症因子的影响[J].中国现代药物应用,2021,15(9):148-150.
[6] 赖伟兰,蔡海荣,郭永宁,等.不稳定型心绞痛患者中医证型与心理状态的关系[J].中国医药,2018,13(1):14-17.
[7] 王多德,席孝萍,刘吉宗,等.当归四逆汤治疗阴寒凝滞型冠心病不稳定性心绞痛疗效观察[J].西部中医药,2021, 34(5):120-121.
[8] 李爱勇,尚菊菊,邢文龙,等.益气逐瘀法对不稳定型心绞痛气虚血瘀证患者择期PCI围术期心脏局部RASS系统的影响[J].北京中医药,2018,37(6):500-503.
[9] 王燕,吴晖,吴诗青.耳穴贴压联合正念减压疗法对冠心病PCI术后心理障碍患者生活质量的影响[J].现代中医药,2021,41(1):86-91.
[10] 中华医学会心血管病学分会,中华心血管病杂志编辑委员会.非ST段抬高型急性冠状动脉综合征诊断和治疗指南(2016)[J].中华心血管病杂志,2017,45(5):359-376.
[11] 中华中医药学会心血管病分会.冠心病心绞痛介入前后中医诊疗指南[J].中国实验方剂学杂志,2018,24(15): 4-6.
[12] Raphael C,Briscoe C,Davies J,et al. Limitations of the New York Heart Association functional classification system and self-reported walking distances in chronic heart failure [J]. Heart,2007,93(4):476-482.
[13] 白文红,其其格.125例冠心病不稳定型心绞痛中医证候分布特征[J].内蒙古中医药,2012,31(1):105-107.
[14] 国家中医药管理局.胸痹心痛的诊断依据、证候分类、疗效评定——中华人民共和国中医药行业标准《中医内科病证诊断疗效标准》(ZY/T001.1-94)[J].辽宁中医药大学学报,2016,18(7):32.
[15] 刘芙君,陈黎明,王勇.冠心病患者冠状动脉支架置入术后电针刺激双侧内关穴、郄门穴预防支架内再狭窄效果观察[J].山东医药,2022,62(35):75-77.
[16] 张叶,李森军.药物涂层球囊治疗冠状动脉药物涂层支架内再狭窄的疗效分析[J].医学临床研究,2022,39(1):135-137.
[17] 张明明,王朝亮,张静,等.探讨豁痰化瘀汤联合硝酸异山梨酯片治疗不稳定心绞痛的疗效[J].环球中医药,2021,14(1):162-165.
[18] 史艳华,臧冬梅,孟祥慧.脑心通胶囊联合尼可地尔治疗微血管性心绞痛的临床研究[J].现代药物与临床,2022, 37(12):2770-2775.
[19] 樊明媛,李雪萍,芮思艳,等.冠心病PCI支架植入术后1年再入院的中医证素分布规律及相关危险因素分析[J].中西医结合心脑血管病杂志,2022,20(15):2783-2787.
[20] 魏宇萌,张明雪.浅析从五脏论治冠心病合并高血压病[J].辽宁中医药大学学报,2022,24(5):92-95.
[21] 宋威,张智菲.养心汤辅助治疗不稳定型心绞痛疗效及对血脂代谢、Cys-C、Hcy水平的影响[J].四川中医,2018, 36(11):89-91.
[22] 贾淑红,王燕丽,吴之煌,等.益心方治疗气虚血瘀型不稳定型心绞痛的临床效果及对患者血液流变学参数的影响[J].中国医药,2021,16(2):175-178.
[23] 张伟,顾宁.冠心Ⅴ号方联合耳穴压豆治疗不稳定型心绞痛气阴亏虚夹瘀证临床研究[J].陕西中医,2021,42(9):1289-1292.
[24] 郭晓梅,刘艳军,翟瑶瑶.耳穴贴压联合增强型体外反搏及心可舒片治疗气滞血瘀型冠心病伴焦虑抑郁的临床疗效及对患者心理状态和炎症因子的影响[J].河北中医,2022,44(9):1530-1534.
[25] 刘世杰,吴磊,郭亚荣,等.灯盏生脉胶囊对不稳定型心绞痛经皮冠状动脉介入术后血液流变学、心肌保护、血小板功能的影响[J].中华中医药学刊,2022,40(2):198- 201.
[26] 耿彬,苗华为,王思洲,等.活血化瘀养心通络方联合替格瑞洛治疗冠心病经皮冠状动脉介入术术后心绞痛的临床疗效及对血管内皮功能及炎症因子的影响[J].中华中医药学刊,2020,38(11):33-37.
[27] 徐晓雨,刘福明.活血通脉法治疗冠心病的研究进展[J].吉林中医药,2021,41(9):1256-1260. |
|
|
|